Martin Shkreli’s other pharma company is dramatically collapsing | Ars Technica


Following arrest of CEO, KaloBios loses CFO, accountants, is delisted from Nasdaq.

Source: Martin Shkreli’s other pharma company is dramatically collapsing | Ars Technica

Leave a Reply

Your email address will not be published. Required fields are marked *

2 × 5 =